NovAccess Global Inc.
OTC: XSNX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dwain K. Morris-Irvin
- Employees
- 3
- Headquarters
- Chesterland, United States
- IPO year
- 1998
- Market cap
- $6.2K
- Website
- https://novaccessglobal.com
Loading XSNX…
Loading profile data…Frequently asked questions about XSNX
What does NovAccess Global Inc. (XSNX) do?
Operating as a biopharmaceutical firm, NovAccess Global Inc. focuses on developing innovative immunotherapies to treat individuals with brain tumors across the United States. Their primary expertise is in pioneering research that leverages a patient's own immune system to target and eliminate cancerous cells. The company, founded in 1997, has it...
Where does XSNX trade?
NovAccess Global Inc. (XSNX) trades on the Other OTC.
What sector is XSNX in?
NovAccess Global Inc. (XSNX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of NovAccess Global Inc.?
Dwain K. Morris-Irvin is the chief executive officer of NovAccess Global Inc. (XSNX).
Where is NovAccess Global Inc. headquartered?
NovAccess Global Inc. is headquartered in United States.
Does XSNX pay a dividend?
NovAccess Global Inc. (XSNX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did XSNX go public?
NovAccess Global Inc. (XSNX) completed its initial public offering in 1998.